CVC  Alexandria Real Estate Equities

http://www.are.com/





     Office Locations:

400 Technology Square, Suite 101
Cambridge, MA 02139
Phone: 508-755-4249

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Alexandria Equities, LLC is the strategic investment entity of Alexandria Real Estate Equities, Inc. (ARE: NYSE). Alexandria Equities provides capital to the broad and diverse life science sector. Since 1994, Alexandria Real Estate has created first-in-class life science clusters that foster innovative and collaborative environments in key locations immediately proximate to leading research institutions. Alexandria's diverse tenant base includes internationally renowned academic and medical institutions, multinational pharmaceutical companies, leading private and public biotechnology entities, non-profit institutions, government agencies, medical device companies, biofuels companies, research tools and service companies, and venture capitalists.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Amanda Cashin PhD Senior Vice President
    Andres Gavinet Chief Accounting Officer
    Daniel J. Ryan Executive VP and Regional Market Director
    Dean A. Shigenaga Chief Financial Officer & Treasurer
    Jennifer J. Banks Executive Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      01/03/2018


      Expansion Therapeutics


      CA


      $55,300,000


      Series A


      12/06/2017


      Obsidian Therapeutics


      MA


      $49,500,000


      Series A


      10/02/2017


      KSQ Therapeutics


      MA


      $76,000,000


      


      09/18/2017


      LifeMine Therapeutics


      MA


      $55,000,000


      Series A


      08/23/2017


      GNS Healthcare


      MA


      $6,000,000


      


      07/24/2017


      Effector Therapeutics


      CA


      $38,600,000


      Series C


      04/26/2017


      Arsanis


      MA


      $45,500,000


      Series D


      04/11/2017


      Frequency Therapeutics


      MA


      $32,000,000


      Series A


      03/30/2017


      Antiva Biosciences


      CA


      $22,000,000


      Series C


      03/25/2017


      eGenesis


      MA


      $38,000,000


      Series A


      03/10/2017


      OncoResponse


      TX


      $22,500,000


      Series A


      02/01/2017


      Kinestral Technologies


      CA


      $65,000,000


      Series C


     

    Portfolio companies include:

     

    Recent News:


      There is no recent news for Alexandria Real Estate Equities.